Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-13-017899
Filing Date
2013-03-27
Accepted
2013-03-27 16:19:50
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-Q v338816_10qa.htm 10-Q/A 446864
2 EXHIBIT 31.1 v338816_ex31-1.htm EX-31.1 10227
3 EXHIBIT 31.2 v338816_ex31-2.htm EX-31.2 10230
4 EXHIBIT 32.1 v338816_ex32-1.htm EX-32.1 3966
5 EXHIBIT 32.2 v338816_ex32-2.htm EX-32.2 3909
  Complete submission text file 0001144204-13-017899.txt   3077597

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT crmd-20120930.xml EX-101.INS 285714
7 XBRL TAXONOMY EXTENSION SCHEMA crmd-20120930.xsd EX-101.SCH 41577
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crmd-20120930_cal.xml EX-101.CAL 31317
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crmd-20120930_def.xml EX-101.DEF 179079
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE crmd-20120930_lab.xml EX-101.LAB 338165
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crmd-20120930_pre.xml EX-101.PRE 213029
Mailing Address 745 ROUTE 202-206 SUITE 303 BRIDGEWATER NJ 08807
Business Address 745 ROUTE 202-206 SUITE 303 BRIDGEWATER NJ 08807 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-34673 | Film No.: 13720247
SIC: 2834 Pharmaceutical Preparations